GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,114,000 | -14.8% | 48,547 | -14.8% | 0.00% | 0.0% |
| Q1 2022 | $2,482,000 | -1.9% | 56,966 | -4.3% | 0.00% | 0.0% |
| Q4 2021 | $2,531,000 | +18.5% | 59,507 | +5.4% | 0.00% | 0.0% |
| Q3 2021 | $2,136,000 | -8.8% | 56,447 | -4.9% | 0.00% | 0.0% |
| Q2 2021 | $2,342,000 | +13.1% | 59,328 | +2.2% | 0.00% | 0.0% |
| Q1 2021 | $2,071,000 | +19.4% | 58,036 | +23.2% | 0.00% | 0.0% |
| Q4 2020 | $1,734,000 | -55.5% | 47,113 | -54.5% | 0.00% | -60.0% |
| Q3 2020 | $3,898,000 | -8.2% | 103,550 | -0.3% | 0.01% | 0.0% |
| Q2 2020 | $4,248,000 | -14.5% | 103,901 | -20.6% | 0.01% | -37.5% |
| Q1 2020 | $4,967,000 | -68.6% | 130,813 | -61.1% | 0.01% | -55.6% |
| Q4 2019 | $15,825,000 | +171.4% | 336,569 | +146.4% | 0.02% | +157.1% |
| Q3 2019 | $5,831,000 | +2.4% | 136,621 | -3.9% | 0.01% | 0.0% |
| Q2 2019 | $5,692,000 | -6.9% | 142,212 | -2.8% | 0.01% | 0.0% |
| Q1 2019 | $6,116,000 | +19.4% | 146,353 | +9.2% | 0.01% | 0.0% |
| Q4 2018 | $5,121,000 | -7.0% | 134,033 | -2.2% | 0.01% | +16.7% |
| Q3 2018 | $5,506,000 | -16.8% | 137,087 | -16.5% | 0.01% | -14.3% |
| Q2 2018 | $6,618,000 | +0.4% | 164,179 | -2.7% | 0.01% | -12.5% |
| Q1 2018 | $6,594,000 | +20.7% | 168,778 | +9.6% | 0.01% | +33.3% |
| Q4 2017 | $5,462,000 | -86.4% | 153,989 | -84.5% | 0.01% | -88.0% |
| Q3 2017 | $40,262,000 | -4.3% | 991,683 | +1.6% | 0.05% | -7.4% |
| Q2 2017 | $42,086,000 | +2.7% | 976,023 | +0.4% | 0.05% | +1.9% |
| Q1 2017 | $40,971,000 | +63.0% | 971,788 | +48.9% | 0.05% | +55.9% |
| Q4 2016 | $25,136,000 | -61.3% | 652,724 | -56.7% | 0.03% | -61.4% |
| Q3 2016 | $64,997,000 | -0.6% | 1,506,999 | -0.1% | 0.09% | -2.2% |
| Q2 2016 | $65,411,000 | +1.1% | 1,509,256 | -5.4% | 0.09% | +1.1% |
| Q1 2016 | $64,685,000 | +21.3% | 1,595,190 | +20.7% | 0.09% | +27.1% |
| Q4 2015 | $53,309,000 | -7.2% | 1,321,155 | -11.6% | 0.07% | -5.4% |
| Q3 2015 | $57,442,000 | +0.9% | 1,493,943 | +9.3% | 0.07% | +17.5% |
| Q2 2015 | $56,944,000 | +6.5% | 1,367,194 | +18.0% | 0.06% | +10.5% |
| Q1 2015 | $53,452,000 | +49.3% | 1,158,226 | +38.2% | 0.06% | +54.1% |
| Q4 2014 | $35,813,000 | +26.2% | 837,944 | +35.7% | 0.04% | +27.6% |
| Q3 2014 | $28,387,000 | +215.4% | 617,521 | +266.9% | 0.03% | +222.2% |
| Q2 2014 | $9,000,000 | -1.5% | 168,289 | -1.6% | 0.01% | 0.0% |
| Q1 2014 | $9,140,000 | -4.7% | 171,068 | -4.7% | 0.01% | -10.0% |
| Q4 2013 | $9,587,000 | -51.1% | 179,566 | -56.1% | 0.01% | -16.7% |
| Q3 2013 | $19,601,000 | +105.2% | 409,394 | +114.1% | 0.01% | +9.1% |
| Q2 2013 | $9,553,000 | – | 191,175 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |